Educational content only. Not medical advice. The content creators are not doctors or medical professionals. Consult your healthcare provider before taking any action.
Why Bloodwork Matters
Peptides influence complex biological systems—metabolism, hormones, immune function, and tissue repair. Blood testing provides objective data about how your body is responding. Without it, you're navigating blind. For peptide users monitoring sex-steroid or GH-axis effects, the relevant evaluation frameworks are the Endocrine Society Clinical Practice Guidelines for testosterone therapy in hypogonadism (Bhasin 2018)[NaN]
Baseline bloodwork establishes your starting point. Follow-up testing reveals trends. Together, they help you optimize protocols and catch problems early.
When to Test
Testing Schedule
| Timing | Purpose |
|---|---|
| Baseline | Before starting any peptide — establishes your normal |
| 4-6 weeks | Early check for concerning changes |
| 12 weeks | Assess protocol effectiveness and safety |
| Ongoing | Every 3-6 months during long-term use |
| Symptom-driven | Whenever something seems off |
Testing Tips
- Fast for 10-12 hours before morning blood draws (water is fine)
- Consistent timing — Same time of day for comparable results
- Avoid intense exercise 24 hours before testing
- Note your cycle — Hormone levels vary throughout menstrual cycle
- List all supplements — They can affect results
Universal Baseline Panel
Everyone using peptides should test these markers before starting:
Metabolic Panel
- Comprehensive Metabolic Panel (CMP)
- Glucose (fasting)
- Kidney function: BUN, Creatinine, eGFR
- Liver function: AST, ALT, Alkaline Phosphatase, Bilirubin
- Electrolytes: Sodium, Potassium, Chloride, CO2
Lipid Panel
- Complete Lipid Panel
- Total Cholesterol
- LDL Cholesterol
- HDL Cholesterol
- Triglycerides
- VLDL (calculated)
Blood Count
- Complete Blood Count (CBC) with Differential
- Red blood cells, hemoglobin, hematocrit
- White blood cells with differential
- Platelets
Thyroid Function
- TSH (minimum)
- Free T4 (recommended)
- Free T3 (if thyroid issues suspected)
Inflammation Markers
- High-Sensitivity C-Reactive Protein (hs-CRP)
- Erythrocyte Sedimentation Rate (ESR) (optional)
GLP-1 Agonist Testing
For semaglutide, tirzepatide, and similar medications.
Before Starting
- All universal baseline markers (above)
- HbA1c — Glycated hemoglobin (3-month glucose average)
- Fasting Insulin — Assess insulin sensitivity
- Lipase and Amylase — Pancreatic enzyme baseline
At 4-6 Weeks
- Fasting Glucose — Check for hypoglycemia risk
- Kidney Function (BUN, Creatinine) — Dehydration monitoring
- Electrolytes — Vomiting can cause imbalances
At 12 Weeks and Ongoing
- Full metabolic panel
- HbA1c — Should be improving if elevated at baseline
- Complete lipid panel — Often improves significantly
- Lipase — Rule out subclinical pancreatitis
- Thyroid panel — Calcitonin if thyroid nodules develop
Red Flag Values
| Marker | Concerning Level | Action |
|---|---|---|
| Lipase | >3x upper limit | Stop, seek evaluation |
| Creatinine | Rising trend | Assess hydration, kidney function |
| Glucose | <70 mg/dL | Evaluate diabetes medication doses |
BPC-157 and TB-500 Testing
Healing peptides have less established monitoring protocols. Focus on safety markers.
Before Starting
- All universal baseline markers
- Comprehensive Metabolic Panel — Liver and kidney baseline
- CBC — Important if any bleeding/clotting concerns
At 8-12 Weeks
- CMP — Ensure liver and kidney function unchanged
- CBC — Monitor for any blood count changes
- Inflammatory markers — Track healing response
If Using for Specific Conditions
GI Issues (BPC-157):
- Consider stool testing if GI symptoms
- Iron studies if GI bleeding history
Injury Recovery (TB-500):
- Imaging appropriate to injury (before/after comparison)
- Inflammatory markers to track healing
Growth Hormone Secretagogue Testing
For CJC-1295, Ipamorelin, MK-677, and similar compounds.
Before Starting
- All universal baseline markers
- IGF-1 — Growth hormone surrogate marker
- Fasting Glucose and Insulin — GH affects glucose metabolism
- HbA1c — If any diabetes risk
At 4-6 Weeks
- Fasting Glucose — GH secretagogues can raise blood sugar
- IGF-1 — Should show increase if compound is working
At 12 Weeks and Ongoing
- IGF-1 — Optimal range 150-250 ng/mL (age-dependent)
- Fasting Glucose and HbA1c — Monitor for glucose intolerance
- Thyroid Panel — GH affects thyroid hormone conversion
- Lipid Panel — GH influences lipid metabolism
- Full metabolic panel
Special Considerations
- PSA (men over 40) — GH can influence prostate
- Mammogram/breast exam (women) — GH affects tissue growth
- Colonoscopy per age guidelines — GH affects cell proliferation
Red Flag Values
| Marker | Concerning Level | Action |
|---|---|---|
| IGF-1 | >350 ng/mL | Reduce dose or discontinue |
| Fasting Glucose | >125 mg/dL | Evaluate, may need to stop |
| HbA1c | Rising trend | Reassess protocol |
Thymic Peptide Testing
For Thymosin Alpha-1, Thymalin, and immune-modulating peptides.
Before Starting
- All universal baseline markers
- Immune panel:
- WBC with differential
- Lymphocyte subsets (CD4, CD8, NK cells) if available
- Inflammatory markers: hs-CRP, ESR
- ANA (if autoimmune history) — Antinuclear antibody
At 8-12 Weeks
- CBC with differential — Monitor immune cell populations
- Inflammatory markers — Should be improving if elevated
- Thyroid panel — Thymic peptides can affect thyroid
Special Considerations
For those with autoimmune conditions:
- Disease-specific markers (e.g., RF for rheumatoid arthritis)
- Consider more frequent testing (every 4 weeks initially)
- Close provider supervision essential
Understanding Your Results
Reference Ranges vs. Optimal Ranges
Lab reference ranges show "normal" for the general population. Optimal ranges for health optimization are often narrower:
| Marker | Reference Range | Optimal Range |
|---|---|---|
| Fasting Glucose | 65-99 mg/dL | 75-90 mg/dL |
| HbA1c | <5.7% | <5.3% |
| hs-CRP | <3.0 mg/L | <1.0 mg/L |
| TSH | 0.4-4.0 mIU/L | 1.0-2.5 mIU/L |
| Triglycerides | <150 mg/dL | <100 mg/dL |
| HDL | >40 mg/dL (M), >50 (F) | >60 mg/dL |
Tracking Trends
Individual values matter less than trends over time. Key questions:
- Is this marker moving in the right direction?
- Is the rate of change appropriate?
- Are improvements sustainable?
Getting Tested
Options for Bloodwork
Through Your Doctor:
- Insurance may cover routine panels
- Easier to discuss results with provider
- Medical record documentation
Direct-to-Consumer Labs:
- Order tests yourself without prescription
- Services: Ulta Lab Tests, Walk-In Lab, Life Extension
- Pay out of pocket, but often competitive pricing
- Results sent directly to you
At-Home Testing:
- Finger prick tests for some markers
- Less comprehensive but convenient
- Good for frequent monitoring between full panels
Cost Considerations
Typical costs without insurance:
- Basic metabolic panel: $20-50
- Comprehensive panel (CMP + CBC + lipids + thyroid): $100-200
- IGF-1: $50-80
- Specialized immune panels: $150-400
Checklist Summary
Minimum Testing Protocol
Before Starting Any Peptide:
- CMP (Comprehensive Metabolic Panel)
- CBC (Complete Blood Count)
- Lipid Panel
- TSH
- hs-CRP
Add Based on Protocol:
- GLP-1 agonists: HbA1c, Lipase
- GH secretagogues: IGF-1, Fasting Insulin
- Thymic peptides: Lymphocyte subsets (if available)
Follow-Up Testing:
- 4-6 weeks: Targeted check based on protocol
- 12 weeks: Comprehensive retest
- Every 3-6 months: Ongoing monitoring
Key Takeaways
- Baseline is essential — You can't assess change without a starting point
- Track trends, not just values — Direction matters more than single results
- Test proactively — Don't wait for symptoms
- Work with providers — Share results with your healthcare team
- Document everything — Keep organized records of all testing
This content is produced by the Peptides.NYC editorial team from published research. It has not been reviewed by a licensed clinician and is educational only — always consult your healthcare provider before starting, stopping, or adjusting any peptide protocol.
Written By
Editorial team. We cite published research; we are not licensed clinicians and content is not medically reviewed.
This article cites peer-reviewed research and medical literature. Click any reference to view the original source.
- 1
Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA (2018) Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline Journal of Clinical Endocrinology & Metabolism.
- 2
Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline Journal of Clinical Endocrinology & Metabolism.
- 3
Newman CB, Blaha MJ, Boord JB, Cariou B, Chait A, Fein HG, Ginsberg HN, Goldberg IJ, Murad MH, Subramanian S, Tannock LR (2020) Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline Journal of Clinical Endocrinology & Metabolism.
Medical Disclaimer
The information on this website is for educational purposes only and is not medical advice. The content creators are not doctors or medical professionals. This content should not be used to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare provider before starting any new supplement, medication, or health protocol. You assume all risks associated with using this information.